Danaher Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, everybody. I'm Tycho Peterson from the life science team. It's my pleasure to introduce our next company this morning, Danaher.
Just a quick reminder for people that have questions, you can submit questions through the ask a question function on the website. And with that, let me turn it over to Rainer.
Well, thank you, Tycho, and good morning, and thank you also to JPMorgan for hosting. I certainly hope we can all be together in person again here real soon. Now I know we have some slides for you to view. So let's go to the second slide here. Just briefly, that's our forward-looking statements, and those are there for your reference. But we can now jump right into really the third slide.
And let me start with an update on our preliminary results for the fourth quarter of 2021. As you likely saw, we made an announcement earlier this morning around our preliminary look at the fourth
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |